
Tremfya Crohns Induction Coupons & Discount Card – Guaranteed Prices from $14499.19
My prescription
Edit
2 solution auto-injectors 2ML of 200MG/2ML, Tremfya Crohns Induction (1 Pen)
Select pharmacy

CVS
$14747.45
COUPON PRICE
Rite Aid
$14499.19
COUPON PRICE
Walmart
$15100.98
COUPON PRICE
Walgreens
$15111.97
COUPON PRICETremfya Crohns Induction savings card
Show this card to your pharmacist
Rite Aid
$14499.19
BIN
ID
PCN
GRP
019876
LH540F4452
CHIPPO
LHX
Powered by
Tremfya Crohns Induction Side Effects
When using this medication, you might experience mild side effects such as bruising, redness, itching, pain, or swelling at the injection site. These are usually temporary, but if they persist or worsen, it's important to seek advice from a healthcare professional.
While serious side effects are less common, it's essential to be aware of them. These include symptoms of liver disease, such as persistent nausea, vomiting, loss of appetite, abdominal pain, yellowing of the skin or eyes, and dark urine. The medication may also impair your ability to fight infections, making you more susceptible to severe infections. Symptoms of an infection to watch for include a persistent sore throat, fever, chills, or cough.
Though very rare, serious allergic reactions can occur. If you experience signs such as a rash, swelling (particularly of the face, tongue, or throat), severe dizziness, or difficulty breathing, seek emergency medical attention immediately. If you notice any other unusual effects, consult a healthcare provider. Remember, not all potential side effects are listed here, and professional guidance is always recommended if you have concerns.
Can TREMFYA be used for Crohn's disease?
Tremfya (guselkumab) is not approved for the treatment of Crohn's disease. It is primarily indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis. Patients should consult their healthcare provider for appropriate treatment options for Crohn's disease.
Can Tremfya help with Crohn's disease?
Tremfya (guselkumab) is not approved for the treatment of Crohn's disease. It is primarily used for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis. Patients should consult with their healthcare provider for appropriate treatment options for Crohn's disease.